No picture, placeholder image
No picture, placeholder image
Faculty of Health Sciences oystein.k.moe@uit.no Tromsø

Øystein Kittel Moe



  • Øystein Kittel Moe, Qian Gao, Dawei Geng, Einar Jensen, Rasmus Goll, Oddmund Nestegard et al.:
    Marked mucosal lipid shifts in treatment refractory inflammatory bowel disease: a lipidomic study
    BMC Gastroenterology 2025 DOI
  • Rasmus Goll, Øystein Kittel Moe, Kay-Martin Johnsen, Renate Weenås Meyer, Joachim Friestad, Mona Dixon Gundersen et al.:
    Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease
    BMC Gastroenterology 2022 DOI / ARKIV
  • Kay-Martin Johnsen, Jon Florholmen, Øystein Kittel Moe, Mona Dixon Gundersen, Julia Beilfuss, Hege Kileng et al.:
    Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study
    BMC Gastroenterology 2022 DOI / ARKIV
  • Jon Florholmen, Kay-Martin Johnsen, Renate Weenås Meyer, Trine Olsen, Øystein Kittel Moe, Petter Tandberg et al.:
    Discovery and validation of mucosal TNF expression combined with histological score-a biomarker for personalized treatment in ulcerative colitis
    BMC Gastroenterology 2020 DOI / ARKIV
  • Rasmus Goll, Richard Heitmann, Øystein Kittel Moe, Carlsen Katrine, Jon Florholmen :
    Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis
    PLOS ONE 02. December 2019 DOI / ARKIV / FULLTEKST

  • The 50 latest publications is shown on this page. See all publications in Cristin here →